Wasatch Advisors’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-335,969
| Closed | -$12.4M | – | 250 |
|
2023
Q3 | $12.4M | Buy |
335,969
+4,610
| +1% | +$171K | 0.08% | 135 |
|
2023
Q2 | $13.3M | Sell |
331,359
-2,814
| -0.8% | -$113K | 0.08% | 145 |
|
2023
Q1 | $24.2M | Sell |
334,173
-1,468
| -0.4% | -$106K | 0.15% | 119 |
|
2022
Q4 | $27.5M | Buy |
335,641
+10,186
| +3% | +$835K | 0.19% | 106 |
|
2022
Q3 | $30.8M | Buy |
325,455
+120,386
| +59% | +$11.4M | 0.21% | 101 |
|
2022
Q2 | $39.9M | Buy |
205,069
+52,125
| +34% | +$10.2M | 0.25% | 95 |
|
2022
Q1 | $35.5M | Buy |
152,944
+71,923
| +89% | +$16.7M | 0.17% | 113 |
|
2021
Q4 | $31.9M | Sell |
81,021
-35,279
| -30% | -$13.9M | 0.13% | 140 |
|
2021
Q3 | $52M | Buy |
116,300
+20,770
| +22% | +$9.29M | 0.21% | 107 |
|
2021
Q2 | $37.1M | Buy |
95,530
+14,252
| +18% | +$5.54M | 0.15% | 132 |
|
2021
Q1 | $29.2M | Buy |
81,278
+2,232
| +3% | +$801K | 0.13% | 136 |
|
2020
Q4 | $38.8M | Sell |
79,046
-30,293
| -28% | -$14.9M | 0.19% | 106 |
|
2020
Q3 | $35.4M | Buy |
109,339
+87,087
| +391% | +$28.2M | 0.23% | 105 |
|
2020
Q2 | $8.11M | Buy |
22,252
+16,662
| +298% | +$6.07M | 0.06% | 171 |
|
2020
Q1 | $1.19M | Sell |
5,590
-38,454
| -87% | -$8.18M | 0.01% | 220 |
|
2019
Q4 | $18.1M | Buy |
44,044
+16,972
| +63% | +$6.99M | 0.15% | 116 |
|
2019
Q3 | $9.56M | Buy |
27,072
+2,854
| +12% | +$1.01M | 0.09% | 139 |
|
2019
Q2 | $12.2M | Buy |
24,218
+7,146
| +42% | +$3.59M | 0.12% | 125 |
|
2019
Q1 | $17M | Buy |
17,072
+3,065
| +22% | +$3.05M | 0.18% | 95 |
|
2018
Q4 | $12.2M | Buy |
14,007
+13,436
| +2,353% | +$11.7M | 0.16% | 100 |
|
2018
Q3 | $590K | Sell |
571
-50
| -8% | -$51.7K | 0.01% | 230 |
|
2018
Q2 | $571K | Buy |
621
+215
| +53% | +$198K | 0.01% | 260 |
|
2018
Q1 | $395K | Buy |
+406
| New | +$395K | 0.01% | 283 |
|